IEAG Findings 5-6 December 2005

Similar documents
Achieving Polio Eradication in India. Emergency Preparedness and Response Plan 2011

Polio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

23rd Meeting of the India Expert Advisory Group for Polio Eradication (IEAG) Delhi, India, July Conclusions and Recommendations

Our Opportunity to make ZERO a Reality!

Pakistan & Afghanistan: Will we soon see the end of polio?

Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO

Immunization and Vaccine Development (IVD) SEARO

Wild Poliovirus Weekly Update

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN

Polio Eradication Initiative Afghanistan

22nd Meeting of the India Expert Advisory Group for Polio Eradication Delhi, India, 1-2 November Conclusions and Recommendations

Expanded Programme on Immunization (EPI)

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING. Gavi Board pre-meeting December 9, 2014, Geneva.

Accelerating Emergency Polio Eradication Activities. SAGE, November 6, 2012

Immunization and Vaccine Development (IVD) SEARO

Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO

Overview of the Polio Country Situation

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

20 th Meeting of the India Expert Advisory Group for Polio Eradication Delhi, India, June Conclusions and Recommendations

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Media centre Statement on the 7th IHR Emergency Committee meeting regarding the international spread of poliovirus

Status of Outbreak Vulnerable Countries

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

Dr. Roma Solomon, CORE India Director

Pakistan Polio Program Update. Independent Monitoring Board, July 2016

Update on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK

Expanded Programme on Immunization (EPI)

BEST PRACTICES IN MICROPLANNING IN AREAS WITH POOR ACCESS

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

HOA Outbreak Response assessment. Kenya 8 th to 12 th June 2015

AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO

Table 1: Basic information 2017

Context 4.1 WHERE WE ARE TODAY. Figure 2: Countries with cases of wild poliovirus, 2011 and 2012

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Expanded Programme on Immunization (EPI)

Wild poliovirus type 1 and Circulating vaccine-derived poliovirus cases

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Global Polio Eradication & Endgame Strategy. December 2015

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

宮村参考人提出資料 資料 2-2

Poliovirus : éradication pour les prochaines JNI?

Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal

Expanded Programme on Immunization (EPI)

Syria cvdpv2 outbreak Situation Report # 18

Syria cvdpv2 outbreak Situation Report # October 2017

Poliomyelitis eradication in the WHO European Region

WHE Situation Report. June, 2018 Situation Report No M KEY FIGURES HIGHLIGHTS. There has been significant decrease in the

VPD in Mediterranean Basin and Black Sea: the Polio case

POLIO ERADICATION AND POST-CERTIFICATION STRATEGY

Immunization Plus Days: Polio Eradication Initiative in Kaduna, Northern Nigeria. Nonso Njokanma September 19, 2006

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

The Polio Endgame

Polio and measles control: opportunities and threats for health systems

Highlighting in the WHO European Region:

Polio Eradication; Update on Situation in Pakistan. Meeting of the independent Monitoring Board for GPEI 1 st October 2013

Eradicating Polio: It's Feasibility in Near Future?

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Getting to Zero: On the Verge of Polio Eradication. Ellyn Ogden, MPH USAID Worldwide Polio Eradication Coordinator May 17, 2017

Poliomyelitis: successful and critical issues in the eradication process

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Manojkumar Choudhary 1, Roma Solomon, Jitendra Awale and Rina Dey

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Programme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017

34th Meeting of the Expert Review Committee on Polio Eradication and Routine Immunization, Nigeria Findings and Recommendations

Status of oral polio vaccination program for international travellers and its determinants: an experience from a designated centre of West Bengal

TECHNICAL ADVISORY GROUP ON POLIO ERADICATION IN THE HORN OF AFRICA

Development of the Polio Eradication and Endgame Strategic plan

Polio Eradication: Beginning of the End, or End of the Beginning?

Preparing for the withdrawal of all oral polio vaccines (OPVs): Replacing trivalent OPV with bivalent OPV

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

Update on Polio Eradication in the World Health Organization South-East Asia Region, 2013

Vaccination Recommendations for Travellers from Polio-infected Countries: Report of the SAGE Polio Working Group

Global ProhrammeUpdate?

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Global Polio Partners Group Monitoring Framework for the GPEI Polio Eradication & Endgame Strategic Plan

WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC

POLIO POST-CERTIFICATION STRATEGY. Summary overview 8 August 2017

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

Syndromic Surveillance in Integrated Disease Surveillance Project (IDSP) and Pre Hospital Emergency Care in India

OVERVIEW OF THE POLIO ERADICATION AND ENDGAME STRATEGIC PLAN AND THE topv TO bopv SWITCH

3. CONCLUSIONS AND RECOMMENDATIONS

Edinburgh Research Explorer

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

Report of the Polio WG Meeting February Dr. Peter Figueroa Co-Chair, SAGE Polio Working Group 17 April, 2018

Progress report on eradication of poliomyelitis: regional implications of the endgame strategy

24 OCTOBER 2012 ANNEX

Week-06 Ending 11 February 2018

BEST PRACTICE FOR MONITORING THE QUALITY OF POLIO ERADICATION CAMPAIGN PERFORMANCE

Somalia polio outbreak update

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Progress report on. Eradication of poliomyelitis

Transcription:

IEAG Findings 5-6 December 005

Surveillance Quality

Surveillance Indicators India 005* 5.47 8% Less than 60% 60% to 69% 70% to 79% 80% and above No AFP case * data as on 6th November 005

AFP cases India 1998-005 4000 000 0000 18000 16000 14000 1000 10000 8000 6000 4000 000 0 3979 3513 1384 9466 9587 9705 8103 8508 7470 1998 1999 000 001 00 003 004 005 AFP Non AFP

Epidemiology of Polio in India

Number of cases 800 Monthly incidence of polio in India January 1998 September 005* NID NID NID SNID SNID NID SNID NID SNID NID SNID NID Mop-up NID SNID NID SNID 700 600 500 400 300 00 100 0 Jan- 9 8 Mar- 98 M ay- 9 8 Jul- 98 Sep-98 N ov- 98 Jan- 9 9 Mar- 99 M ay- 9 9 Jul- 99 Sep-99 N ov- 99 Jan- 0 0 Mar- 00 M ay- 0 0 Jul- 00 Sep-00 N ov- 00 Jan- 0 1 Mar- 01 M ay- 0 1 Jul- 01 Sep-01 N ov- 01 Jan- 0 Mar- 0 M ay- 0 Jul- 0 Sep-0 N ov- 0 Jan- 0 3 Mar- 03 M ay- 0 3 Jul- 03 Sep-03 N ov- 03 Jan- 0 4 Mar- 04 M ay- 0 4 Jul- 04 Sep-04 N ov- 04 Jan- 0 5 Mar- 05 M ay- 0 5 Jul- 05 Sep-05 1998 1999 000 001 00 003 004 005 NID National Immunization Day SNID Sub-National Immunization Day Large scale mop-up * data as on 9 th November, 005

800 700 600 500 400 300 00 100 P3 Virus: Number of cases by year 0 1998 1999 000 001 00 003 004 005

Characteristics of Polio Cases India, 005* >=10 doses 33% 0 dose 0% 1-3 doses 9% 4-6 doses 8% 4-59 mths 36% 60+ mths % <1 mths 31% 7-9 doses 30% 1-3 mths 31% OPV Status AGE * data as on 1 st December 005

Wild polio cases by Community, 005 Bihar 005* Uttar Pradesh 005* Hindu 54% Muslim 46% Hindu 4% Muslim 58% (N=4) (N=4)

Most recent virus 13 th October 005, Sitamarhi Location of poliovirus, 005* (53 cases) Polio in AFP Uttar Pradesh Bihar Jharkhand Delhi Uttaranchal Punjab 4 4 1 1 1 * data as on 9 th November, 005

* data as on 1 st December, 005 Spread of polio from Bihar, 005 # # # # # # # # # # # # # # # # # # # # # # # Nepal # # # # # # # ### # # # # # # # # # # # # # %

SIA Quality in High Risk Areas

100% 80% 60% 40% 0% Immunization Status (children < 5 years) Uttar Pradesh 0-3 doses 4-6 doses 0% Bihar 100% 1 3 4 1 3 4 1 3 4 1 1999 000 001 00 003 004 3 4 1 3 4 1 3 4 1 3 005* 80% 60% 40% 0% 0% 1 3 * data as on 6th November 005 4 1 3 4 1 3 4 1 1999 000 001 00 003 004 005* 3 4 1 3 4 1 3 4 1 3

Supervisors Cross-checking Work September 005 93% 8% West UP < 80 % 80% to 90% > 90% Bihar

Comparison of PPI Coverage Number of children in million 0 18 16 14 1 10 8 0 19.6 19.5 19.7 0. 0.3 0.4 0.4 0.3 0.4 6 ~ 43.5% increase in April 05 coverage over Oct 04 40 38 36 34 3 30 0 Oct-04 Nov-04 Jan-05 Feb-05 Apr-05 May-05 Jun-05 Aug-05 Sep-05 35. 36.4 37.4 Bihar still has 1-14% of houses with missed children vs. just 6-8% in UP. 38.5 39.0 39.3 39.0 38.9 38.7 8 6 ~ 411% increase in April 05 coverage over Oct 04 Oct-04 Nov-04 Jan-05 Feb-05 Apr-05 May-05 Jun-05 Aug-05 Sep-05 Bihar Uttar Pradesh

Teams not working by SIA microplan May 05 Sep 05 7.3% 9.1%

Impact of mopv1

Summary of mopv1 Use, 005 4-6 mopv1 rds, Apr-Nov in the 3 reservoir areas. 1 round rounds 4 rounds 5 rounds 6 rounds 300 m doses used in Apr-Nov 005

Number of Polio cases, India 10 100 116 104 80 60 40 3 36 0 0 5 8 003 004 005 February April May October Data as of nd December 005

WPV1 Positive Mumbai Sewage Samples Jan 04 Oct 05 topv mopv1 topv % positive for Wild P 1 100% 90% 80% 70% 60% 50% 40% 30% 0% 10% 0% J- 04 F M A M J J A S O N D J- 05 58% +ve in May-Oct '04 vs. 7% in same period in 005. F M A M J J A S O Month of sample collection August, September, October isolates are importations

P1 wild, 004-005 16 13 high risk districts-up 16 Bihar 14 14 1 1 10 10 8 8 6 6 4 4 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 004 005 004 005 Data as of nd December 005

Proportion of AFP with Wild Poliovirus by season & state, 003-005 Positive AFP Cases (%) 6 5 4 3 1 mopv1 Uttar Pradesh Bihar 0 Low 03 High 03 Low 04 High 04 Low 05 High 05

Summary Introduction of mopv1 & innovative SIA approaches has reduced polio to lowest incidence and geographic extent ever. Progress is fragile, and Bihar now poses highest risk, as evidenced by recent exports to Jharkhand, Punjab and Nepal. The enhanced impact of mopv1 during the low season could stop all polio in early-006.

topv Immune Response & Season * Mumbai, India, 1977 100 90 Seroconversion (%) 80 70 60 50 40 30 0 10 0 I II III Poliovirus Type High (Feb-Apr) Low (Nov-Jan) * Pangi NS, Master JM, Dave KH. Ind Ped XIV(7); 1977.

Recommendations

Programme Priorities Bihar: districts in north east, north west & Patna are the highest priority due to: high case numbers, geographic extent, exportations to polio-free areas, suboptimal SIA quality. Uttar Pradesh: western districts remain very high priority due to ongoing WPV1 transmission & last type 3 isolations.

State Government Oversight Bihar: Build on engagement of new Chief Minister with full polio briefing, as soon as possible. Propose biweekly CM briefing during the critical 3 month period through end-feb. CS to consider (a) weekly oversight of Jan/Feb preps (esp. high priority districts) and (b) establish Polio Task Force & Polio Cell. UP: sustain high level State Government & District Administration oversight of eradication activities.

Recommended SIA Schedule NIDs NIDs SNIDs SNIDs SNIDs Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 006 007

SNIDs Jan-Feb 006 Extent: all of UP, Bihar, Delhi, Greater Mumbai/Thane & selected districts of Jharkhand and Uttaranchal. Vaccine: mopv1 in WUP, Bihar & Greater Mumbai; elsewhere topv. International Coordination: with infected areas of Nepal.

Vaccine mopv1: use in all SIAs in all areas of known type 1 transmission & at highest risk. topv: use for all routine immunization activities and SIAs in polio-free states. mopv3: use in all SIAs responding to WPV3; in absence of WPV3, and if feasible, mopv3 could be used in at least 1 rd in WUP districts at highest risk of WPV3.

Enhancing SIA Impact 1 Continue Recent Innovations: High Risk Area (HRA) approach. Underserved strategies. Transit sites (incl. railway plan). Deploy as many SMOs as possible to HRAs (esp. in Bihar), to facilitate SIA planning, monitoring, etc in Jan/Feb. Expand SM Net as proposed in Bihar & ensure adequate resources for same.

Enhancing SIA Impact - Bihar State government: consider assigning a senior IAS Officer on Special Duty to oversee day-to-day operations with CS & Secretary for FW. District & Block Administrations: Ensure existing/acting DMOs & MOICs fully involved in block level planning/preps; DM to monitor engagement. if positions vacant, immediately assign DMO & MCIO polio responsibilities to other, existing staff. December Planning Meeting: review & enhance mechanisms for reaching missed children (i.e. X houses, revisiting, children outside households)

Surveillance NPSP should continue current approach to monitor & address state & sub-state surveillance issues. During the detailed investigations of 'hot cases' and virus-confirmed cases, the IEAG reaffirms the importance of also reviewing the history of compatible cases in the area.

Routine Immunization IEAG notes the work to implement national & state routine EPI plans and recommends: Enhanced work, under the NTAG, to link the monitoring of outreach sessions to coverage data. High priority districts in WUP & Bihar should be targeted for intensive efforts to improve routine immunization. Consideration should be given to expanding external monitoring activities to other states.

Summary

Summary Introduction of mopv1 & innovative SIA approaches has reduced polio to lowest incidence and geographic extent ever. Progress is fragile, and Bihar now poses highest risk, as evidenced by recent exports to Jharkhand, Punjab and Nepal. Enhanced impact of mopv1 during low season could stop all polio in early-006. Strong partner support to GoI is essential.